Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping
- PMID: 15667213
- DOI: 10.1021/bi048032c
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping
Abstract
Solvent mapping moves molecular probes, small organic molecules containing various functional groups, around the protein surface, finds favorable positions, clusters the conformations, and ranks the clusters based on the average free energy. Using at least six different solvents as probes, the probes cluster in major pockets of the functional site, providing detailed and reliable information on the amino acid residues that are important for ligand binding. Solvent mapping was applied to 12 structures of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand-binding domain (LBD), including 2 structures without a ligand, 2 structures with a partial agonist, and 8 structures with a PPAR agonist bound. The analysis revealed 10 binding "hot spots", 4 in the ligand-binding pocket, 2 in the coactivator-binding region, 1 in the dimerization domain, 2 around the ligand entrance site, and 1 minor site without a known function. Mapping is a major source of information on the role and cooperativity of these sites. It shows that large portions of the ligand-binding site are already formed in the PPARgamma apostructure, but an important pocket near the AF-2 transactivation domain becomes accessible only in structures that are cocrystallized with strong agonists. Conformational changes were seen in several other sites, including one involved in the stabilization of the LBD and two others at the region of the coactivator binding. The number of probe clusters retained by these sites depends on the properties of the bound agonist, providing information on the origin of correlations between ligand and coactivator binding.
Similar articles
-
Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.Biochemistry. 2006 Aug 8;45(31):9393-407. doi: 10.1021/bi060343v. Biochemistry. 2006. PMID: 16878974
-
Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.Proteins. 2005 Feb 1;58(2):418-25. doi: 10.1002/prot.20266. Proteins. 2005. PMID: 15558556
-
Partial agonists activate PPARgamma using a helix 12 independent mechanism.Structure. 2007 Oct;15(10):1258-71. doi: 10.1016/j.str.2007.07.014. Structure. 2007. PMID: 17937915
-
Peroxisome proliferator-activated receptor gamma in malignant diseases.Crit Rev Oncol Hematol. 2006 Apr;58(1):1-14. doi: 10.1016/j.critrevonc.2005.08.011. Epub 2006 Jan 18. Crit Rev Oncol Hematol. 2006. PMID: 16388966 Review.
-
Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.Biol Pharm Bull. 2021;44(9):1185-1195. doi: 10.1248/bpb.b21-00263. Biol Pharm Bull. 2021. PMID: 34471046 Review.
Cited by
-
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function.Front Immunol. 2021 Feb 26;12:630569. doi: 10.3389/fimmu.2021.630569. eCollection 2021. Front Immunol. 2021. PMID: 33717162 Free PMC article. Review.
-
Discrimination of Dendropanax morbifera via HPLC fingerprinting and SNP analysis and its impact on obesity by modulating adipogenesis- and thermogenesis-related genes.Front Nutr. 2023 Aug 2;10:1168095. doi: 10.3389/fnut.2023.1168095. eCollection 2023. Front Nutr. 2023. PMID: 37621738 Free PMC article.
-
Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?Cardiovasc Diabetol. 2008 Mar 20;7:6. doi: 10.1186/1475-2840-7-6. Cardiovasc Diabetol. 2008. PMID: 18355413 Free PMC article.
-
To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations.PPAR Res. 2020 Apr 1;2020:5314187. doi: 10.1155/2020/5314187. eCollection 2020. PPAR Res. 2020. PMID: 32308671 Free PMC article.
-
The PPAR Ω Pocket: Renewed Opportunities for Drug Development.PPAR Res. 2020 Jul 1;2020:9657380. doi: 10.1155/2020/9657380. eCollection 2020. PPAR Res. 2020. PMID: 32695150 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources